If we can better detect and monitor MS, we can reduce the long-term impact of the disorder.
In this accessible presentation for a general audience, Dr Cornfeld explains how the Ultra High Contrast MRI method developed at the Mātai Medical Research Institute could support earlier and more accurate diagnosis of Multiple Sclerosis.
Methamphetamine addiction costs New Zealand $1.5B per year. See how we're helping overcome the problem.
The goal of the Mātai pathway is increasing the accuracy of the prostate cancer diagnosis and advocating for guided biopsy as a national standard of care, to improve outcomes and equity in prostate cancer screening and diagnosis.